Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(100 sites)
United States
The University of Alabama at Birmingham Clinical Research Unit (CRU), Birmingham, Alabama Mayo Clinic, Scottsdale, Arizona Urological Associates of South Arizona, Tucson, Arizona Arkansas Urology, Little Rock, Arkansas University of California - Irvine Medical Center, Irvine, California UC San Diego Moores Cancer Center, La Jolla, California USC/Norris Comprehensive Cancer Center, Los Angeles, California Tower Urology, Los Angeles, California Genesis Research, San Diego, California Colorado Clinical Research, Lakewood, Colorado The George Washington Medical Faculty Associates, Washington D.C., District of Columbia University of Florida, Jacksonville, Florida Sylvester Comprehensive Cancer Center / University of Miami Hospital and Clinics, Miami, Florida Emory University, Atlanta, Georgia Rush University Medical Center, Chicago, Illinois Urology of Indiana, Greenwood, Indiana University of Kansas Medical Center, Kansas City, Kansas John Hopkins Hospital, Baltimore, Maryland Chesapeake Urology Research Associates, Hanover, Maryland Brigham and Women's Hospital, Boston, Massachusetts Henry Ford Health System, Detroit, Michigan Corewell Health Medical Group and Spectrum Health Hospitals, Grand Rapids, Michigan University of Minnesota, Minneapolis, Minnesota Mayo Clinic, Rochester, Minnesota Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey New Jersey Urology, LLC, Voorhees Township, New Jersey Albany Medical College, Albany, New York Mount Sinai Medical Center, New Haven, New York Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York, New York Associated Medical Professionals of NY,, Syracuse, New York UNC Chapel Hill Hospital, Chapel Hill, North Carolina Duke Health - Duke Cancer Center, Durham, North Carolina Associated Urologists of North Carolina, Raleigh, North Carolina University of Cincinnati Medical Center, Cincinnati, Ohio Central Ohio Urology Group, Gahanna, Ohio Clinical Research Solutions - Helios Clinical Research, Middleburg Heights, Ohio Oregon Health & Science University (OHSU), Portland, Oregon Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia, Pennsylvania Carolina Urologic Research Center, LLC, Myrtle Beach, South Carolina Urology Associates, P.C., Nashville, Tennessee Vanderbilt Univerity Medical Center, Nashville, Tennessee Urology Austin, Austin, Texas UT Southwestern Medical Center, Dallas, Texas Houston Metro Urology, Houston, Texas Houston Methodist Hospital - Department of Urology, Houston, Texas University of Texas - MD Anderson Cancer Center, Houston, Texas Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah University of Virginia Comprehensive Cancer Center, Charlottesville, Virginia Froedtert Hospital / Medical College of Wisconsin, Milwaukee, Wisconsin Australia
Sydney Adventist Hospital, Wahroonga, New South Wales Gold Coast University Hospital, Southport, Queensland Icon Cancer Center Windsor Gardens, Windsor Gardens, South Australia Canada
Prostate Cancer Centre, Calgary, Alberta Vancouver Prostate Centre, Vancouver, British Columbia Nova Scotia Health Authority, Halifax, Nova Scotia University Health Network, Princess Margaret Cancer Centre, Toronto, Ontario McGill University Health Center - Glen site, Montreal, Quebec CHUM Centre Hospitalier de l Universite de Montreal, Montreal, Quebec France
CHU Bordeaux Pellegrin, Bordeaux lnstitut Bergonie 229 Cour de l'Argonne, Bordeaux Hospices Civils de Lyon, Lyon Hopital Bichat Claude-Bernard, Paris CHU de Rauen- Hopital Charles Nicolle, Rouen Germany
Klinik fur Urologie, Uro-Onkologie, spezielle urologische und Roboter-assistierte Chirurgie Universitatsklinikum Koln (AOR), Cologne Urologicum Duisburg, Duisburg Universitaetsklinikum Erlangen, Erlangen Urologie Neandertal Mettmann, Mettmann Studienpraxis Urologie, Nürtingen Universitaetsklinikum Tubingen, Tübingen Italy
Clinic Unit of Urology, IRCCS Ospedale San Raffaele, Milan, MI Istituto Europeo di Oncologia, Milan Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples Fondazione Policlinico Universitario "A.Gemelli" IRCCS, Largo, Rome Azienda Ospedaliero-Universitaria Sant'Andrea, Rome UOC Urologia, IFO- lstituto Tumori "Regina Elena", Rome South Korea
Seoul National University Bundang Hospital, Seongnam, Gyunggi-do Chonnam National University Hwasun Hospital, Hwasun, Jeollanam-do Seoul National University Hospital, Seoul Severance Hospital, Yonsei University Health System, Seoul The Catholic University of Korea, Soul St. Mary's Hospital, Seoul Spain
IOB - Hospital Quironsalud Barcelona, Barbera Del Valles Fundacio Puigvert, Barcelona Hospital Clinic Barcelona, Barcelona Hospital Germans Trias i Pujol, Barcelona Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat Hospital General Universitario Gregorio Maranon, Madrid Hospital Universitario 12 de Octubre, Madrid Hospital Universitario La Paz, Madrid Hospital Quironsalud Madrid (Next Oncology), Madrid Hospital Universitario Infanta Sofia, Madrid Hospital General Universitario Morales Meseguer, Murcia Hospital Universitario Marqués de Valdecilla,, Santander Taiwan
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City China Medical University Hospital, Taichung Taichung Veterans General Hospital, Taichung Chi Mei Medical Center, Tainan National Taiwan University Hospital, Taipei United Kingdom
The Royal Marsden NHS Foundation Trust, London